OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Microbiota-induced lipid peroxidation impairs obeticholic acid-mediated antifibrotic effect towards nonalcoholic steatohepatitis in mice
Aoxiang Zhuge, Shengjie Li, Yin Yuan, et al.
Redox Biology (2022) Vol. 59, pp. 102582-102582
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Hepatic glycogenesis antagonizes lipogenesis by blocking S1P via UDPG
Jie Chen, Yabo Zhou, Zhuohang Liu, et al.
Science (2024) Vol. 383, Iss. 6684
Closed Access | Times Cited: 22

FXR agonists for MASH therapy: Lessons and perspectives from obeticholic acid
Kang Wang, Yuecan Zhang, Guangji Wang, et al.
Medicinal Research Reviews (2023) Vol. 44, Iss. 2, pp. 568-586
Closed Access | Times Cited: 25

Circadian Control of Hepatic Ischemia/Reperfusion Injury via HSD17B13-Mediated Autophagy in Hepatocytes
Hui Wang, Meina Guo, Baoyin Ren, et al.
Journal of Hepatology (2025)
Closed Access | Times Cited: 1

Protective Effect of Berberine on Acute Gastric Ulcer by Promotion of Tricarboxylic Acid Cycle-Mediated Arachidonic Acid Metabolism
Qiuyan Guo, Tianming Lu, Min Zhang, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 15-28
Open Access | Times Cited: 8

Gut microbiota in health and disease: advances and future prospects
Y J Zhang, Hong Wang, Yingpeng Sang, et al.
MedComm (2024) Vol. 5, Iss. 12
Open Access | Times Cited: 8

Ferroptosis: a potential bridge linking gut microbiota and chronic kidney disease
Zi‐Hui Mao, Zhong‐Xiuzi Gao, Shaokang Pan, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 6

Understanding the role of ursodeoxycholic acid and gut microbiome in non-alcoholic fatty liver disease: current evidence and perspectives
Qingyi Mao, Beibei Lin, Wenluo Zhang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5

Sedanolide alleviates DSS-induced colitis by modulating the intestinal FXR-SMPD3 pathway in mice
Shengjie Li, Aoxiang Zhuge, Hui Chen, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 5

Emerging mechanisms of non-alcoholic steatohepatitis and novel drug therapies
Hao Chen, Yang Zhou, Haiping Hao, et al.
Chinese Journal of Natural Medicines (2024) Vol. 22, Iss. 8, pp. 724-745
Closed Access | Times Cited: 5

Intermittent fasting regulates gut microbiota and serum metabolome profiles in middle-aged mice fed high-fat diet
Ziru Li, Sufang Chen, Baoshu Yin, et al.
Nutrition & Metabolism (2025) Vol. 22, Iss. 1
Open Access

Gut microbiota-mediated bile acid transformations regulate the transport of aflatoxin B1 from the intestine to the liver in piglets
Jiangdi Mao, Yusen Wei, Zhixiang Ni, et al.
Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology (2025) Vol. 16, Iss. 1
Open Access

Gypenoside XIII regulates lipid metabolism in HepG2 hepatocytes and ameliorates nonalcoholic steatohepatitis in mice
Shu‐Chen Cheng, Chian‐Jiun Liou, Ya‐Xuan Wu, et al.
The Kaohsiung Journal of Medical Sciences (2024) Vol. 40, Iss. 3, pp. 280-290
Open Access | Times Cited: 3

Association between gut microbiota and acute pancreatitis: a bidirectional Mendelian randomization study
Feng Zhou, Yang Liu, Yanqing Shi, et al.
Journal of Gastroenterology and Hepatology (2024) Vol. 39, Iss. 9, pp. 1895-1902
Closed Access | Times Cited: 2

Identification of chikusetsusaponin IVa as a novel lysine-specific demethylase 1 inhibitor that ameliorates high fat diet-induced MASLD in mice
Yuwen Liu, Ren Luo, Anqi Liu, et al.
Acta Pharmacologica Sinica (2024)
Closed Access | Times Cited: 2

Lipid Peroxidation in Ferroptosis and Association with Nonalcoholic Fatty Liver Disease
Shengnan Zhao, Guo Yan, Xunzhe Yin
Frontiers in Bioscience-Landmark (2023) Vol. 28, Iss. 12, pp. 332-332
Open Access | Times Cited: 5

Luteoloside mitigates premature age-related macular degeneration by suppressing p53-p21-Rb1 axis: Insights from transcriptomic analysis, serum metabolomics and gut microbiota analysis
Yuhan Song, Dandan Wei, Qi Wang, et al.
Journal of Pharmaceutical and Biomedical Analysis (2024) Vol. 248, pp. 116296-116296
Closed Access | Times Cited: 1

ROS-responsive nanoparticle delivery of obeticholic acid mitigate primary sclerosing cholangitis
Qigu Yao, Beiduo Wang, Jiong Yu, et al.
Journal of Controlled Release (2024) Vol. 374, pp. 112-126
Open Access | Times Cited: 1

Akkermansia muciniphila-derived acetate activates the hepatic AMPK/SIRT1/PGC-1α axis to alleviate ferroptosis in metabolic-associated fatty liver disease
Aoxiang Zhuge, Shengjie Li, Shengyi Han, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 15, Iss. 1, pp. 151-167
Open Access | Times Cited: 1

Investigating the effects of dexamethasone on pulmonary surfactant lipids based on lipidomics studies
Zhao Wang, Tao Li, Lili Lin, et al.
Biomedical Chromatography (2024) Vol. 38, Iss. 9
Closed Access

Tenascin C-Guided Nanosystem for Precision Delivery of Obeticholic Acid in Liver Fibrosis Therapy
Yawen Wang, Lei Yang, Qing Xu, et al.
Pharmaceutics (2024) Vol. 17, Iss. 1, pp. 32-32
Open Access

Page 1 - Next Page

Scroll to top